A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Bevantolol
Magnesium chloride
Enzalutamide may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
Bevantolol
Sodium acetate
Enzalutamide may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
Bevantolol
Phosphoric acid
Enzalutamide may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
Bevantolol
Dexpanthenol
Enzalutamide may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Bevantolol
Invert sugar
Enzalutamide may decrease the excretion rate of Invert sugar which could result in a higher serum level.
Bevantolol
Antihemophilic Factor (Recombinant), PEGylated
Enzalutamide may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.
Bevantolol
Sodium fluoride
Enzalutamide may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
Bevantolol
Sulbactam
Enzalutamide may decrease the excretion rate of Sulbactam which could result in a higher serum level.
Bevantolol
Procaine benzylpenicillin
Enzalutamide may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Bevantolol
Chondroitin sulfate
Enzalutamide may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
Bevantolol
Sacubitril
Enzalutamide may decrease the excretion rate of Sacubitril which could result in a higher serum level.
Bevantolol
Magnesium trisilicate
Enzalutamide may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
Bevantolol
Sodium aurothiomalate
Enzalutamide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
Bevantolol
Picosulfuric acid
Enzalutamide may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
Bevantolol
Lixisenatide
Enzalutamide may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Bevantolol
Idarucizumab
Enzalutamide may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
Bevantolol
Gimeracil
Enzalutamide may decrease the excretion rate of Gimeracil which could result in a higher serum level.
Bevantolol
Dextran
Enzalutamide may decrease the excretion rate of Dextran which could result in a higher serum level.
Bevantolol
Toloxatone
Enzalutamide may decrease the excretion rate of Toloxatone which could result in a higher serum level.
Bevantolol
Pirlindole
Enzalutamide may decrease the excretion rate of Pirlindole which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3